{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T06:56:31Z","timestamp":1767164191383,"version":"build-2238731810"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1124\/jpet.105.087643","type":"journal-article","created":{"date-parts":[[2005,10,19]],"date-time":"2005-10-19T13:02:49Z","timestamp":1129726969000},"page":"545-552","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["RETRACTION: Human Expanded Polyglutamine Androgen Receptor Mutants in Neurodegeneration as a Novel Ligand Target"],"prefix":"10.1016","volume":"315","author":[{"given":"Takashi","family":"Furutani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken-ichi","family":"Takeyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Tanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Koutoku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saya","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuaki","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eriko","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Kudoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Shibasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisataka","family":"Shikama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeaki","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.105.087643_bib1","doi-asserted-by":"crossref","unstructured":"Arrasate M, Mitra S, Schweitzer ES, Segal MR, and Finkbeiner S (2004) Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature (Lond) 431: 805-810.","DOI":"10.1038\/nature02998"},{"key":"10.1124\/jpet.105.087643_bib2","doi-asserted-by":"crossref","unstructured":"Brzozowski AM, Pike AC, Dauter Z, Hubbard RE, Bonn T, Engstrom O, Ohman L, Greene GL, Gustafsson JA, and Carlquist M (1997) Molecular basis of agonism and antagonism in the oestrogen receptor. Nature (Lond) 389: 753-758.","DOI":"10.1038\/39645"},{"key":"10.1124\/jpet.105.087643_bib3","doi-asserted-by":"crossref","unstructured":"Chatterjee B, Song CS, Jung MH, Chen S, Walter CA, Herbert DC, Weaker FJ, Mancini MA, and Roy AK (1996) Targeted overexpression of androgen receptor with a liver-specific promoter in transgenic mice. Proc Natl Acad Sci USA 93: 728-733.","DOI":"10.1073\/pnas.93.2.728"},{"key":"10.1124\/jpet.105.087643_bib4","doi-asserted-by":"crossref","unstructured":"Cheng Y and Prusoff WH (1973) Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22: 3099-3108.","DOI":"10.1016\/0006-2952(73)90196-2"},{"key":"10.1124\/jpet.105.087643_bib5","doi-asserted-by":"crossref","unstructured":"Choong CS and Wilson EM (1998) Trinucleotide repeats in the human androgen receptor: a molecular basis for disease. J Mol Endocrinol 21: 235-257.","DOI":"10.1677\/jme.0.0210235"},{"key":"10.1124\/jpet.105.087643_bib6","doi-asserted-by":"crossref","unstructured":"Cousty-Berlin D, Bergaud B, Bruyant MC, Battmann T, Branche C, and Philibert D (1994) Preliminary pharmacokinetics and metabolism of novel non-steroidal anti-androgens in the rat: relation of their systemic activity to the formation of a common metabolite. J Steroid Biochem Mol Biol 51: 47-55.","DOI":"10.1016\/0960-0760(94)90114-7"},{"key":"10.1124\/jpet.105.087643_bib7","doi-asserted-by":"crossref","unstructured":"Freedman LP (1999) Increasing the complexity of coactivation in nuclear receptor signaling. Cell 97: 5-8.","DOI":"10.1016\/S0092-8674(00)80708-4"},{"key":"10.1124\/jpet.105.087643_bib8","doi-asserted-by":"crossref","unstructured":"Furutani T, Watanabe T, Tanimoto K, Hashimoto T, Koutoku H, Kudoh M, Shimizu Y, Kato S, and Shikama H (2002) Stabilization of androgen receptor protein is induced by agonist, not by antagonists. Biochem Biophys Res Commun 294: 779-784.","DOI":"10.1016\/S0006-291X(02)00564-8"},{"key":"10.1124\/jpet.105.087643_bib9","doi-asserted-by":"crossref","unstructured":"Glass CK and Rosenfeld MG (2000) The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev 14: 121-141.","DOI":"10.1101\/gad.14.2.121"},{"key":"10.1124\/jpet.105.087643_bib10","doi-asserted-by":"crossref","unstructured":"He B, Kemppainen JA, Voegel JJ, Gronemeyer H, and Wilson EM (1999) Activation function 2 in the human androgen receptor ligand binding domain mediates interdomain communication with the NH(2)-terminal domain. J Biol Chem 274: 37219-37225.","DOI":"10.1074\/jbc.274.52.37219"},{"key":"10.1124\/jpet.105.087643_bib11","doi-asserted-by":"crossref","unstructured":"Ito S, Takeyama K, Yamamoto A, Sawatsubashi S, Shirode Y, Kouzmenko A, Tabata T, and Kato S (2004) In vivo potentiation of human oestrogen receptor alpha by Cdk7-mediated phosphorylation. Genes Cells 9: 983-992.","DOI":"10.1111\/j.1365-2443.2004.00777.x"},{"key":"10.1124\/jpet.105.087643_bib12","doi-asserted-by":"crossref","unstructured":"Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, Masushige S, Gotoh Y, Nishida E, Kawashima H, et al. (1995) Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science (Wash DC) 270: 1491-1494.","DOI":"10.1126\/science.270.5241.1491"},{"key":"10.1124\/jpet.105.087643_bib13","doi-asserted-by":"crossref","unstructured":"Kawano H, Sato T, Yamada T, Matsumoto T, Sekine K, Watanabe T, Nakamura T, Fukuda T, Yoshimura K, Yoshizawa T, et al. (2003) Suppressive function of androgen receptor in bone resorption. Proc Natl Acad Sci USA 100: 9416-9421.","DOI":"10.1073\/pnas.1533500100"},{"key":"10.1124\/jpet.105.087643_bib14","doi-asserted-by":"crossref","unstructured":"Kazemi-Esfarjani P and Benzer S (2000) Genetic suppression of polyglutamine toxicity in Drosophila. Science (Wash DC) 287: 1837-1840.","DOI":"10.1126\/science.287.5459.1837"},{"key":"10.1124\/jpet.105.087643_bib15","doi-asserted-by":"crossref","unstructured":"Kinoyama I, Taniguchi N, Yoden T, Koutoku H, Furutani T, Kudoh M, and Okada M (2004) Synthesis and pharmacological evaluation of novel arylpiperazine derivatives as nonsteroidal androgen receptor antagonists. Chem Pharm Bull (Tokyo) 52: 1330-1333.","DOI":"10.1248\/cpb.52.1330"},{"key":"10.1124\/jpet.105.087643_bib16","doi-asserted-by":"crossref","unstructured":"Kouzmenko AP, Takeyama K, Ito S, Furutani T, Sawatsubashi S, Maki A, Suzuki E, Kawasaki Y, Akiyama T, Tabata T, and Kato S (2004) Wnt\/beta-catenin and estrogen signaling converge in vivo. J Biol Chem 279: 40255-40258.","DOI":"10.1074\/jbc.C400331200"},{"key":"10.1124\/jpet.105.087643_bib17","doi-asserted-by":"crossref","unstructured":"La Spada AR, Wilson EM, Lubahn DB, Harding AE, and Fischbeck KH (1991) Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature (Lond) 352: 77-79.","DOI":"10.1038\/352077a0"},{"key":"10.1124\/jpet.105.087643_bib18","doi-asserted-by":"crossref","unstructured":"Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, and Evans RM (1995) The nuclear receptor superfamily: the second decade. Cell 83: 835-839.","DOI":"10.1016\/0092-8674(95)90199-X"},{"key":"10.1124\/jpet.105.087643_bib19","doi-asserted-by":"crossref","unstructured":"McKenna NJ and O\u2019Malley BW (2002) Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 108: 465-474.","DOI":"10.1016\/S0092-8674(02)00641-4"},{"key":"10.1124\/jpet.105.087643_bib20","unstructured":"Merry DE and Fischbeck KH (1998) Genetics and molecular biology of the androgen receptor CAG repeat, in Genetic Instability and Hereditary Neurological Disease (Wells RD and Warren ST eds) pp 101-111, Academic Press, New York."},{"key":"10.1124\/jpet.105.087643_bib21","doi-asserted-by":"crossref","unstructured":"Mooradian AD, Morley JE, and Korenman SG (1987) Biological actions of androgens. Endocr Rev 8: 1-28.","DOI":"10.1210\/edrv-8-1-1"},{"key":"10.1124\/jpet.105.087643_bib22","doi-asserted-by":"crossref","unstructured":"Moses K and Rubin GM (1991) Glass encodes a site-specific DNA-binding protein that is regulated in response to positional signals in the developing Drosophila eye. Genes Dev 5: 583-593.","DOI":"10.1101\/gad.5.4.583"},{"key":"10.1124\/jpet.105.087643_bib23","doi-asserted-by":"crossref","unstructured":"Poujol N, Wurtz JM, Tahiri B, Lumbroso S, Nicolas JC, Moras D, and Sultan C (2000) Specific recognition of androgens by their nuclear receptor. A structure-function study. J Biol Chem 275: 24022-24031.","DOI":"10.1074\/jbc.M001999200"},{"key":"10.1124\/jpet.105.087643_bib24","doi-asserted-by":"crossref","unstructured":"Sato T, Matsumoto T, Kawano H, Watanabe T, Uematsu Y, Sekine K, Fukuda T, Aihara K, Krust A, Yamada T, et al. (2004) Brain masculinization requires androgen receptor function. Proc Natl Acad Sci USA 101: 1673-1678.","DOI":"10.1073\/pnas.0305303101"},{"key":"10.1124\/jpet.105.087643_bib25","doi-asserted-by":"crossref","unstructured":"Sato T, Matsumoto T, Yamada T, Watanabe T, Kawano H, and Kato S (2003) Late onset of obesity in male androgen receptor-deficient (AR KO) mice. Biochem Biophys Res Commun 300: 167-171.","DOI":"10.1016\/S0006-291X(02)02774-2"},{"key":"10.1124\/jpet.105.087643_bib26","doi-asserted-by":"crossref","unstructured":"Shang Y, Myers M, and Brown M (2002) Formation of the androgen receptor transcription complex. Mol Cell 9: 601-610.","DOI":"10.1016\/S1097-2765(02)00471-9"},{"key":"10.1124\/jpet.105.087643_bib27","doi-asserted-by":"crossref","unstructured":"Shiau AK, Barstad D, Loria PM, Cheng L, Kushner PJ, Agard DA, and Greene GL (1998) The structural basis of estrogen receptor\/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 95: 927-937.","DOI":"10.1016\/S0092-8674(00)81717-1"},{"key":"10.1124\/jpet.105.087643_bib28","doi-asserted-by":"crossref","unstructured":"Takeyama K, Ito S, Sawatsubashi S, Shirode Y, Yamamoto A, Suzuki E, Maki A, Yamagata K, Zhao Y, Kouzmenko A, et al. (2004) A novel genetic system for analysis of co-activators for the N-terminal transactivation function domain of the human androgen receptor. Biosci Biotechnol Biochem 68: 1209-1215.","DOI":"10.1271\/bbb.68.1209"},{"key":"10.1124\/jpet.105.087643_bib29","doi-asserted-by":"crossref","unstructured":"Takeyama K, Ito S, Yamamoto A, Tanimoto H, Furutani T, Kanuka H, Miura M, Tabata T, and Kato S (2002) Androgen-dependent neurodegeneration by polyglutamine-expanded human androgen receptor in Drosophila. Neuron 35: 855-864.","DOI":"10.1016\/S0896-6273(02)00875-9"},{"key":"10.1124\/jpet.105.087643_bib30","doi-asserted-by":"crossref","unstructured":"Takeyama K, Masuhiro Y, Fuse H, Endoh H, Murayama A, Kitanaka S, Suzawa M, Yanagisawa J, and Kato S (1999) Selective interaction of vitamin D receptor with transcriptional coactivators by a vitamin D analog. Mol Cell Biol 19: 1049-1055.","DOI":"10.1128\/MCB.19.2.1049"},{"key":"10.1124\/jpet.105.087643_bib31","doi-asserted-by":"crossref","unstructured":"Tanimoto H, Itoh S, ten Dijke P, and Tabata T (2000) Hedgehog creates a gradient of DPP activity in Drosophila wing imaginal discs. Mol Cell 5: 59-71.","DOI":"10.1016\/S1097-2765(00)80403-7"},{"key":"10.1124\/jpet.105.087643_bib32","doi-asserted-by":"crossref","unstructured":"Tsuneizumi K, Nakayama T, Kamoshida Y, Kornberg TB, Christian JL, and Tabata T (1997) Daughters against dpp modulates dpp organizing activity in Drosophila wing development. Nature (Lond) 389: 627-631.","DOI":"10.1038\/39362"},{"key":"10.1124\/jpet.105.087643_bib33","doi-asserted-by":"crossref","unstructured":"Watanabe M, Yanagisawa J, Kitagawa H, Takeyama K, Ogawa S, Arao Y, Suzawa M, Kobayashi Y, Yano T, Yoshikawa H, et al. (2001) A subfamily of RNA-binding DEAD-box proteins acts as an estrogen receptor alpha coactivator through the N-terminal activation domain (AF-1) with an RNA coactivator, SRA. EMBO (Eur Mol Biol Organ) J 20: 1341-1352.","DOI":"10.1093\/emboj\/20.6.1341"},{"key":"10.1124\/jpet.105.087643_bib34","doi-asserted-by":"crossref","unstructured":"Wilson JD (1999) The role of androgens in male gender role behavior. Endocr Rev 20: 726-737.","DOI":"10.1210\/edrv.20.5.0377"},{"key":"10.1124\/jpet.105.087643_bib35","doi-asserted-by":"crossref","unstructured":"Yanagisawa J, Kitagawa H, Yanagida M, Wada O, Ogawa S, Nakagomi M, Oishi H, Yamamoto Y, Nagasawa H, McMahon SB, et al. (2002) Nuclear receptor function requires a TFTC-type histone acetyl transferase complex. Mol Cell 9: 553-562.","DOI":"10.1016\/S1097-2765(02)00478-1"},{"key":"10.1124\/jpet.105.087643_bib36","doi-asserted-by":"crossref","unstructured":"Yeh S and Chang C (1996) Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells. Proc Natl Acad Sci USA 93: 5517-5521.","DOI":"10.1073\/pnas.93.11.5517"}],"updated-by":[{"DOI":"10.1124\/jpet.114.03er14b","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2014,2,17]],"date-time":"2014-02-17T00:00:00Z","timestamp":1392595200000},"record-id":"3995"},{"DOI":"10.1124\/jpet.114.03er14b","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000}}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524297111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524297111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.105.087643","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T15:46:47Z","timestamp":1739980007000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524297111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["S0022356524297111"],"URL":"https:\/\/doi.org\/10.1124\/jpet.105.087643","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RETRACTION: Human Expanded Polyglutamine Androgen Receptor Mutants in Neurodegeneration as a Novel Ligand Target","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.105.087643","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2005 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}